<?xml version="1.0" encoding="UTF-8" standalone="yes"?><?xml-stylesheet type="text/xsl" href="/oai-pmh-repository/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2026-10-10T16:15:50Z</responseDate>
    <request verb="GetRecord" identifier="oai:data.mendeley.com/gcy3g4g42j.2" metadataPrefix="oai_dc">https://data.mendeley.com/oai</request>
    <GetRecord>
        <record>
            <header>
                <identifier>oai:data.mendeley.com/gcy3g4g42j.2</identifier>
                <datestamp>2023-11-15T11:07:11Z</datestamp>
            </header>
            <metadata><oai_dc:dc xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <dc:creator>Morel, Anne-Pierre</dc:creator>
    <dc:title>Cooperative pro-tumorigenic adaptation to oncogenic RAS through epithelial to mesenchymal plasticity</dc:title>
    <dc:publisher>Mendeley Data</dc:publisher>
    <dc:description>In breast cancers, aberrant activation of the RAS/MAPK pathway is strongly associated with mesenchymal features and stemness traits, suggesting an interplay between this mitogenic signaling pathway and epithelial-mesenchymal plasticity (EMP). By using inducible models of human mammary epithelial cells, we demonstrate herein that the oncogenic activation of RAS promotes ZEB1-dependent EMP, which is necessary for malignant transformation. Notably, EMP is triggered by the secretion of pro-inflammatory cytokines from neighboring RAS-activated senescent cells, with a prominent role for IL-6 and IL-1. 
Our data contrast with the common view of cellular senescence as a tumor suppressive mechanism and EMP as a process promoting late stages of tumor progression in response to signals from the tumor microenvironment. Indeed, we highlighted here a pro-tumorigenic cellular cooperation of RAS-activated mammary epithelial cells, which leverages on oncogene-induced senescence and EMP to trigger cellular reprogramming and tumor initiation. 
</dc:description>
    <dc:subject>Breast Cancer</dc:subject>
    <dc:subject>Epithelial Mesenchymal Transition</dc:subject>
    <dc:type>Dataset</dc:type>
    <dc:identifier>doi:10.17632/gcy3g4g42j.2</dc:identifier>
    <dc:identifier>oai:data.mendeley.com/gcy3g4g42j.2</dc:identifier>
    <dc:rights>Creative Commons Attribution 4.0 International</dc:rights>
    <dc:rights>http://creativecommons.org/licenses/by/4.0</dc:rights>
    <dc:relation>https://data.mendeley.com/datasets/gcy3g4g42j</dc:relation>
    <dc:date>2023-11-15T11:07:11Z</dc:date>
    <dc:date>2024-02-14T23:59:59Z</dc:date>
</oai_dc:dc></metadata>
        </record>
    </GetRecord>
</OAI-PMH>
